CiteScore measures average citations received per document published in the serial.
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Overview | |
Publisher | MARY ANN LIEBERT, INC |
Language | English |
Frequency | Monthly |
General Details | |
Language | English |
Frequency | Monthly |
Publication Start Year | 1990 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my Paper5.8k articles received 157.3k citations see all
Human Gene Therapy has been in operation since 1990 till date.
Human Gene Therapy published with a Monthly frequency.
In 2023, Human Gene Therapy published 130 articles.
For Human Gene Therapy,eISSN is 1557-7422 and pISSN is1043-0342.
Citescore for Human Gene Therapy is 8.2.
H index for Human Gene Therapy is 156.
SNIP score for Human Gene Therapy is 1.05.
SJR for Human Gene Therapy is Q2.
MARY ANN LIEBERT, INC is the publisher of Human Gene Therapy.